The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the 12 months ended December 31, 2024, and provides updates on its antiviral product pipeline, ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

Proteases that are resident in, or released from, the endolysosomal system of leukocytes have important functions in the immune response. Lysosome-related organelles (LROs) or granules are the ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

Historically, most people started HIV treatment with two drugs from the NRTI class combined with either one NNRTI, one protease inhibitor or one integrase inhibitor – hence, ‘triple therapy’.

Omeros has announced that the activation of clinical trial sites for patient enrolment is now in progress for its Phase III ...

INSTIs belong to a category of drugs known as integrase inhibitors. INSTIs are well-established drugs. Doctors often use ritonavir (Norvir) as a booster drug for protease inhibitors. Due to their ...

Scientists have identified promising drug candidates that bind irreversibly with a notoriously “undruggable” cancer protein ...